• support@madhedgefundtrader.com
  • Member Login
Mad Hedge Fund Trader
  • Home
  • About
  • Store
  • Luncheons
  • Testimonials
  • Contact Us
  • Click to open the search input field Click to open the search input field Search
  • Menu Menu

Tag Archive for: (AAPL)

Mad Hedge Fund Trader

New Video Update on How to Execute a Vertical Bull Call Debit Spread

Diary, Newsletter

I have just updated the training video for Vertical Bull Call Debit Spreads that goes out with every trade alert. With a market meltdown forecast for the new year, some great entry points for these will be setting up.

Since then, we have learned a lot from customer questions. The nature of the options markets has also changed. So, the new video extends to 27:43 minutes. To watch it in its entirety, please click here.

I recommend watching it on full screen so you can read all the numbers on my options trading platform.

We have recently had a large influx of new subscribers.

I have no idea why. Maybe it’s my sterling personality and rapier-like wit.

Most investors make the mistake of investing in positions that have only a 50/50 chance of success, or less. They’d do better with a coin toss.

The most experienced hedge fund traders find positions that have a 99% chance of success and then leverage up on those trades. Stop out of the losers quickly and you have an approach that will make you well into double digits, year in and year out, whether markets go up, down, or sideways.

Bring on the Vertical Bull Call Debit Spread.

This is a matched pair of positions in the options market that will be profitable when the underlying security goes up, sideways, or down in price over a defined limited period of time.

It is the perfect position to have onboard during markets that have declining or low volatility, much like we have experienced for most of the last several years, and will almost certainly see again.

I have strapped on quite a few of these babies across many asset classes this year, and they are a major reason why I am up so much last year.

To understand this trade, I will use the example of Apple trade, which most people own and know well.

On October 8, 2018, I sent out a Trade Alert by text message and email that said the following. Please note these are pre-split prices.

BUY the Apple (AAPL) November 2018 $180-$190 in-the-money vertical BULL CALL spread at $8.80 or best.

At the time, Apple shares were trading at $216.17. To accomplish this, they had to execute the following trades:

Buy 11 November 2018 (AAPL) $180 calls at….………$38.00

Sell short 11 November 2018 (AAPL) $190 calls at….$29.20

Net Cost:…………………….………..………….…..................$8.80

A screenshot of my own trading platform is below:

 

 

This gets traders into the position at $8.80, which costs them $9,680 ($8.80 per option X 100 shares per option X 11 contracts).

The vertical part of the description of this trade refers to the fact that both options have the same underlying security (AAPL), the same expiration date (November 16, 2018), and only different strike prices ($180 and $190).

The maximum potential profit can be calculated as follows:

+$190.00  Upper strike price
 -$180.00  Lower strike price
  +$10.00  Maximum Potential Profit

Another way of explaining this is that the call spread you bought for $8.80 is worth $10.00 at expiration on November 16, giving you a total return of 13.63% in 27 trading days. Not bad!

The great thing about these positions is that your risk is defined. You can’t lose any more than the $9,680 you put up.

If Apple goes bankrupt, we get a flash crash, or suffer another 9/11-type event, you will never get a margin call from your broker in the middle of the night asking for more money. This is why hedge funds like vertical bull call spreads so much.

As long as Apple traded at or above $190 on the November 16 expiration date, you will make a profit on this trade.

As it turns out, my take on Apple shares proved dead-on, and the shares rose to $222.22, or a healthy $32 above my upper strike.

The total profit on the trade came to:

($10.00 expiration - $8.80 cost) = $1.20

($1.20 profit X 100 shares per contract X 11 contracts) = $1,320.

To summarize all of this, you buy low and sell high. Everyone talks about it but very few actually do it.

Occasionally, Vertical Bull Call Spreads don’t work and the wheels fall off. As hard as it may be to believe, I am not infallible.

So if I’m wrong and I tell you to buy a vertical bull call spread, and the shares fall not a little, but a LOT, you will lose money. In those rare cases when that happens, I’ll shoot out a Trade Alert to you with stop-loss instructions before the damage gets out of control.

I start looking at a stop loss when the deficit hit 10% of the size of the position or 1% of the total capital in my trading account.

To watch the video edition of How to Execute a Vertical Bull Call Spread complete with more detailed instructions on how to execute the position with your own online platform, please click here.

Good luck and good trading.

 

 

Vertical Bull Call Spreads Are the Way to Go in a flat to Rising Market

https://www.madhedgefundtrader.com/wp-content/uploads/2018/08/John-on-mechanical-bull-story-1-image-3-e1534972073238.jpg 313 250 Mad Hedge Fund Trader https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png Mad Hedge Fund Trader2025-01-02 09:02:332025-02-20 12:40:42New Video Update on How to Execute a Vertical Bull Call Debit Spread
april@madhedgefundtrader.com

December 31, 2024

Biotech Letter

Mad Hedge Biotech and Healthcare Letter
December 31, 2024
Fiat Lux

 

Featured Trade:

(SOMETIMES WALL STREET GETS IT WRONG)

(BMY), (AAPL), (MRK)

https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png 0 0 april@madhedgefundtrader.com https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png april@madhedgefundtrader.com2024-12-31 12:02:452024-12-31 11:47:45December 31, 2024
april@madhedgefundtrader.com

Sometimes Wall Street Gets It Wrong

Biotech Letter

Sitting in my stateroom aboard the Coral Princess, about 200 miles off Mexico's west coast, I found myself chuckling at the market's reaction to Bristol-Myers Squibb’s (BMY) latest developments. Sometimes Wall Street reminds me of my old physics professor - brilliant but occasionally missing the forest for the quantum trees.

Here's what caught my attention: BMY's stock has outperformed the broader market by +15% since July, yet still trades at a measly 7.91x forward P/E while its sector peers strut around at 20.53x. It's like finding a Ferrari in a used car lot, priced like a Corolla.

The cynics, of course, point to the patent cliff. "What about Eliquis in 2026? Opdivo in 2028?" they ask, wringing their hands. But that's exactly where it gets interesting.

Just earlier this month, BMY announced FDA approval for Opdivo Qvantig - their new subcutaneous version that cuts treatment time from 30 minutes to 5 minutes. If you've ever spent time in cancer treatment centers like I have, you know those 25 minutes make a world of difference.

BMY's commercial team expects this version to capture 75% of Opdivo's business, with 30-40% of patients switching from IV. That's not just convenience - it's strategic patent life extension.

Speaking of strategy, let's talk about their growth portfolio, which has quietly expanded 20% year-over-year and now represents 48.7% of their business.

Remember when Apple (AAPL) transformed from computers to mobile devices? BMY is pulling a similar pivot, just without the flashy keynotes.

Take their $14 billion Karuna acquisition. Their newly approved schizophrenia treatment, Cobenfy, targets a market projected to hit $15.23 billion by 2034. The timing here is masterful - monetization starts in early 2025, well before the patent cliffs hit.

Meanwhile, they're cleaning up their balance sheet faster than a neat freak with a new vacuum. They've already slashed $4.31 billion in debt this year, with plans to cut $10 billion by 2026.

Their free cash flow has grown to $13.8B, up 18.1% sequentially. At this rate, they'll have plenty of dry powder for more strategic moves.

But here's what really makes me scratch my head: while everyone's fixated on the patent cliff, BMY has quietly added 8 new oncology registrational trials in the past year. Their oncology trio - Opdivo, Yervoy, and Opdualag - is growing at 7.6% year-over-year.

Sure, Merck's (MRK) Keytruda is the 800-pound gorilla with $25 billion in sales, but BMY's playing a different game - diversification with shots on goal across multiple therapeutic areas.

Now, I'm not suggesting you back up the truck tomorrow morning. The stock might see some pressure after the January 3, 2025 ex-dividend date, possibly testing support at $51 or even $48. But with a 4.45% dividend yield and a valuation at half its historical average, patient investors might find this an interesting entry point.

Speaking of timing - Wall Street's greatest fortunes were made by investors who saw value where others saw problems. Right now, most analysts are staring at BMY's patent cliff like deer in headlights.

Meanwhile, I'm seeing a company with a 4.45% dividend yield, a growth portfolio expanding at 20% annually, and a valuation that's practically begging to double.

As I wrap this up from somewhere off the Mexican coast (where I'm supposedly on vacation but can't help analyzing stocks between rounds of Monopoly), I'm reminded of something I learned in my decades of trading: The crowd is usually looking through the wrong end of the telescope.

While they're zoomed in on 2026's patent expirations, they're missing the transformation happening right now in front of their eyes.

Maybe that's why I've averaged +50% returns for over a decade - I tend to look where others don't. BMY just might be one of those opportunities that makes next year's Christmas gift to my subscribers an even bigger winner than this year's +75.25% return.

Now, if you'll excuse me, my banjo needs tuning, and I have a Monopoly empire to build. But remember - in both board games and markets, the best players are always thinking three moves ahead. BMY's management certainly is.

 

https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png 0 0 april@madhedgefundtrader.com https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png april@madhedgefundtrader.com2024-12-31 12:00:342024-12-31 11:47:09Sometimes Wall Street Gets It Wrong
april@madhedgefundtrader.com

December 26, 2024

Diary, Newsletter, Summary

Global Market Comments
December 26, 2024
Fiat Lux

 

SPECIAL ISSUE ABOUT THE FAR FUTURE

Featured Trade:
(PEAKING INTO THE FUTURE WITH RAY KURZWEIL),
(GOOG), (INTC), (AAPL), (TXN)

https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png 0 0 april@madhedgefundtrader.com https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png april@madhedgefundtrader.com2024-12-26 09:04:192024-12-26 10:02:24December 26, 2024
april@madhedgefundtrader.com

December 23, 2024

Diary, Newsletter, Summary

Global Market Comments
December 23, 2024
Fiat Lux

 

Featured Trade:

(A BUY WRITE PRIMER)

(AAPL)

https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png 0 0 april@madhedgefundtrader.com https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png april@madhedgefundtrader.com2024-12-23 09:04:282024-12-23 11:34:05December 23, 2024
april@madhedgefundtrader.com

December 13, 2024

Tech Letter

Mad Hedge Technology Letter
December 13, 2024
Fiat Lux

 

Featured Trade:

(THE AI TRAIN KEEPS CHUGGING)
(DELL), (AAPL), (NVDA)

https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png 0 0 april@madhedgefundtrader.com https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png april@madhedgefundtrader.com2024-12-13 14:04:552024-12-13 15:31:41December 13, 2024
april@madhedgefundtrader.com

The AI Train Keeps Chugging

Tech Letter

If anyone needs another AI data point, the tech market just delivered us a juicy one with an outstanding earnings call with Broadcom (AVGO) and its CEO Hock Tan.

The AI enterprise build-out has been developing in full-force and investors are pouring money into the foundation of the AI future.

That is currently where the AI profits currently lie.

The software companies have missed out on that profit in the short-term, but since many are also involved in the AI infrastructure spend, they can turn to their investors and ask for a mark-up in owned shares.

This won’t always be the case, and I do believe we are fast reaching an inflection point where shareholders will demand more from their capital and not just more AI data centers and more modern AI semiconductor chips.

I am talking about meaningful revenue growth directly tied to AI spend – we don’t have that yet. 

At some point, there needs to be an application from all of this money spent and return on capital.

In the meantime, Mr. Market is cheering the success of AVGO and the stock is up 25% today at the time of this writing signaling investors will continue to back this AI infrastructure spend into 2025 and possibly beyond.

Broadcom CEO Hock Tan said the company expects its custom AI chips will generate between $60 billion and $90 billion in revenue over the next three years from its three existing hyperscaler customers, whom the company did not name. Tan reiterated his belief that each of the three hyperscalers will deploy 1 million clusters of its custom AI chips called XPUs by 2025.

Apple is reportedly working with Broadcom to develop an AI server chip. The move by tech giants to make their own server chips is meant to cut costs and scale back their reliance on Nvidia’s (NVDA) GPUs (graphics processing units).

That trend is reflected in the industry at large. The AI chip market is set to grow 74% in 2025, while the semiconductor market overall is projected to grow just 12% next year.

We are seeing this type of binary divergence in tech firms like Dell and Oracle.

Many of these legacy tech companies are attempting to wean themselves from a legacy business that is expanding in the low single digits.

From a technical perspective, any dip to the $200 level will be a strong buy for AVGO.

I believe they continue to pivot into the AI infrastructure build while partnering with companies that can aid this type of success.

They will continue to invest in products related to AI, mainly chips, which will be installed in a wide array of businesses like data centers, consumer electronics like smartphones and laptops, and electric vehicles.

AVGO has been a hot company for quite a while, and even though not quite an Nvidia, I do believe AVGO stock is a solid backup option for tech investors looking for some diversification.

 

 

https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png 0 0 april@madhedgefundtrader.com https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png april@madhedgefundtrader.com2024-12-13 14:02:062024-12-13 15:31:28The AI Train Keeps Chugging
april@madhedgefundtrader.com

December 11, 2024

Tech Letter

Mad Hedge Technology Letter
December 11, 2024
Fiat Lux

 

Featured Trade:

(OPTIMISTIC FUTURE FOR GOOGLE)
(GOOGL), (AAPL)

https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png 0 0 april@madhedgefundtrader.com https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png april@madhedgefundtrader.com2024-12-11 14:04:012024-12-12 11:25:41December 11, 2024
april@madhedgefundtrader.com

Optimistic Future For Google

Tech Letter

It isn’t a surprise that the Department of Justice is going after Google (GOOGL) to divest its Chrome browser following a ruling in August that the company holds a monopoly in the search market.

I don’t believe this will tank the cash cow business of Google Search, and let’s not forget the most likely outcome is that Chrome is retained as a division of Google.

At worst, if it does get divested, the appeal process takes many years. 

Although I do believe it will become harder for Google Search to track and monitor user behavior without Google Chrome, this is by no means a deal breaker.

Plenty of traffic comes from completely different operating systems like Apple (AAPL) iOS that don’t employ the Chrome browser.

In fact, spinning out its browser would result in a massive windfall because the current setup hides the aggregate value and synergies within a larger corporation.

Once Google Chrome is spun out, animal spirits could take hold, and the value could skyrocket.

Google will naturally profit from this as well.

Chrome, which Google launched in 2008, provides the search giant with data it then uses for targeting ads. The DOJ said in a filing that forcing the company to get rid of Chrome would create a more equal playing field for search.

The DOJ said that Google will be prevented from entering into exclusionary agreements with third parties like Apple and Samsung. The department also said that Google be prohibited from giving its search service preference within its other products.

Search advertising accounted for $49.4 billion in revenue, representing three-quarters of total ad sales in the most recent period.

The DOJ’s request represents the agency’s most aggressive attempt to break up a tech company since its antitrust case against Microsoft, which reached a settlement in 2001.

In August, a federal judge ruled that Google holds a monopoly in the search market.

Also, the DOJ suggested limiting or prohibiting default agreements and “other revenue-sharing arrangements related to search and search-related products.”

The most likely outcome is that Google will be legally forced to do away with certain exclusive agreements, like its deal with Apple. I also don’t believe that Google will be forced to divest from the Android operating system, and the chances of that happening are almost zero.

Even without an exclusivity agreement, most Apple users use Google Chrome because it is still the most useful search engine.

Will that be the case in the future?

With AI changing business models left and right, it is hard to say, but in the interim, it is hard to believe that a lack of exclusivity agreement will cause any meaningful change to the bottom or top line in the next few years.

Breaking up parts of Google would result in a massive windfall for shareholders, strengthen the tech ecosystem, and make Google and its spinoff entities more competitive.

However, high-up executives are wary about voluntarily dumping revenue from the mothership because it hurts negotiating leverage when agreeing on future compensation, and that is what usually standalone corporate executives care about.

I believe spinning out some of these businesses, like Waymo, Google devices, Google Maps, and YouTube, would be great for America and give an opportunity for investors to jump into great tech companies before they skyrocket.

 

 

 

https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png 0 0 april@madhedgefundtrader.com https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png april@madhedgefundtrader.com2024-12-11 14:02:002024-12-12 11:25:25Optimistic Future For Google
april@madhedgefundtrader.com

November 27, 2024

Tech Letter

Mad Hedge Technology Letter
November 27, 2024
Fiat Lux

 

Featured Trade:

(BEST BUY THROWS UP SOME WARNING SIGNALS)
(BBY), (AAPL)

https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png 0 0 april@madhedgefundtrader.com https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png april@madhedgefundtrader.com2024-11-27 14:04:002024-11-27 16:09:34November 27, 2024
Page 7 of 112«‹56789›»

tastytrade, Inc. (“tastytrade”) has entered into a Marketing Agreement with Mad Hedge Fund Trader (“Marketing Agent”) whereby tastytrade pays compensation to Marketing Agent to recommend tastytrade’s brokerage services. The existence of this Marketing Agreement should not be deemed as an endorsement or recommendation of Marketing Agent by tastytrade and/or any of its affiliated companies. Neither tastytrade nor any of its affiliated companies is responsible for the privacy practices of Marketing Agent or this website. tastytrade does not warrant the accuracy or content of the products or services offered by Marketing Agent or this website. Marketing Agent is independent and is not an affiliate of tastytrade. 

Legal Disclaimer

There is a very high degree of risk involved in trading. Past results are not indicative of future returns. MadHedgeFundTrader.com and all individuals affiliated with this site assume no responsibilities for your trading and investment results. The indicators, strategies, columns, articles and all other features are for educational purposes only and should not be construed as investment advice. Information for futures trading observations are obtained from sources believed to be reliable, but we do not warrant its completeness or accuracy, or warrant any results from the use of the information. Your use of the trading observations is entirely at your own risk and it is your sole responsibility to evaluate the accuracy, completeness and usefulness of the information. You must assess the risk of any trade with your broker and make your own independent decisions regarding any securities mentioned herein. Affiliates of MadHedgeFundTrader.com may have a position or effect transactions in the securities described herein (or options thereon) and/or otherwise employ trading strategies that may be consistent or inconsistent with the provided strategies.

Copyright © 2025. Mad Hedge Fund Trader. All Rights Reserved. support@madhedgefundtrader.com
Scroll to top